AZ files immunotherapy Imfinzi in Europe

9th October 2017 Uncategorised 0

AstraZeneca has submitted the first marketing application in Europe for its immunotherapy Imfinzi, seeking approval for the drug’s use to treat a subset of patients with lung cancer.

More: AZ files immunotherapy Imfinzi in Europe
Source: News